How Technology Can Reduce Pharmacy Staff Burnout
Drug Topics
NOVEMBER 5, 2024
Companies like ShiftRx are using technology to help solve the staffing shortage crisis in health care.
Tue.Nov 05, 2024
567 
CEO with type 1 diabetes works to deliver ‘world’s first’ functional cure
PharmaVoice
NOVEMBER 5, 2024
Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Two Independent Pharmacies Latest to Sue Major PBMs
Drug Topics
NOVEMBER 5, 2024
A collection of independent pharmacies was the next in line to file suits against major pharmacy benefit managers for alleged drug price fixing.
STAT+: Pharmacies sue GoodRx and PBMs over ‘illegal’ reimbursement fees
STAT
NOVEMBER 5, 2024
Three independent pharmacies have filed separate lawsuits accusing GoodRx, which markets a prescription drug discount card, of conspiring with several pharmacy benefit managers to fix reimbursement fees, the latest skirmish over the opaque pharmaceutical supply chain in the U.S. At issue are the behind-the-scenes transactions involving generic drugs, which account for an estimated 90% of the prescriptions written in the U.S. and, consequently, represent a lucrative market.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Tips For Increasing Your Independent Pharmacy’s Online Visibility | NCPA 2024
Drug Topics
NOVEMBER 5, 2024
Erin Rexroth, director of marketing at NCPA, discusses how smaller pharmacies can compete with large chains when it comes to digital marketing.
AstraZeneca shares tumble after reports China unit is linked to insurance fraud
The Guardian - Pharmaceutical Industry
NOVEMBER 5, 2024
Pharmaceutical’s weight loss pill described as ‘underwhelming’, also piling pressure on share price AstraZeneca shares tumbled on Tuesday wiping £14bn off the value of Britain’s biggest drug maker, after a report that dozens of senior executives at its China unit could be implicated in an insurance fraud case in the country’s pharmaceutical sector. Also putting pressure on the share price, early data on AstraZeneca’s experimental weight loss pill published on Monday was described as “somewhat un
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Study Finds Behaviors of Breast Cancer Cells Help Predict Risk of Bone Metastasis
Pharmacy Times
NOVEMBER 5, 2024
Using in vitro models, study investigators predict the risk of bone metastasis in breast cancer based on correlations with their in vivo behaviors and potential.
FDA Approves Journey Medical’s Emrosi for Rosacea
Drug Topics
NOVEMBER 5, 2024
“Emrosi has potential to become the best-in-class oral medication to treat the condition,” said the CEO of Journey Medical.
FDA Approves DFD-29 for Treatment of Adults With Rosacea-Related Inflammatory Lesions
Pharmacy Times
NOVEMBER 5, 2024
The approval comes after the phase 3 clinical trials MVOR-1 (NCT05296629) and MVOR-2 (NCT05343455).
Effective Ways Pharmacists Can Educate, Encourage Patients to Get Flu Vaccines | NCPA 2024
Drug Topics
NOVEMBER 5, 2024
A conversation with Lauren Angelo, PharmD, MBA, associate dean of academic affairs and an associate professor of pharmacy practice at Rosalind Franklin University of Medicine and Science College of Pharmacy.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Dupilumab Shows Significant Reductions in Itch and Hive Activity in Patients With CSU
Pharmacy Times
NOVEMBER 5, 2024
About 41% and 30% of patients with chronic spontaneous urticaria (CSU), respectively, achieved well-controlled disease status and complete response when treated with dupilumab.
Two former Alexion leaders fight through layoffs and a tough market to maintain a rare disease biotech
PharmaVoice
NOVEMBER 5, 2024
Rallybio is headed into a mid-stage trial with enough cash through 2026, but the cyclical market has made the journey difficult.
Pharmacists Play Key Role in Flu Vaccination Efforts
Pharmacy Times
NOVEMBER 5, 2024
Kristi Veis discusses the importance of flu vaccinations and the role of pharmacists in administering them.
Take Charge of Your Health: A Practical Guide to Diabetes Prevention and Management
Dr. Jamie Hardy: The Lifestyle Pharmacist
NOVEMBER 5, 2024
November is a great time to focus on our health with an emphasis on diabetes awareness. Managing diabetes or preventing it entirely doesn’t mean we need to overhaul our lives overnight—it’s about making small, consistent changes that add up over time. Fun fact- I have a strong family history of diabetes. Fortunately everyone in my family managed it well enough to prevent the serious complications that diabetes is known to cause like amputations, vision loss, and kidney failure.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Researchers Find Lack of Communication for Lung Cancer Screenings Among High-Risk Individuals
Pharmacy Times
NOVEMBER 5, 2024
Less than 16% of high-risk lung cancer individuals have heard or discussed lung cancer screenings with a health care provider.
Intra-Cellular's unstoppable Caplyta nails another trial, this time for relapse prevention in schizophrenia
Fierce Pharma
NOVEMBER 5, 2024
Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial. | Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial.
Study Identifies Which Students at Risk for Pandemic-Related Psychological Distress
Pharmacy Times
NOVEMBER 5, 2024
The results found that women, non-binary, and sexual minority students are at the highest risk.
Beam points to positive data with key base editing asset
pharmaphorum
NOVEMBER 5, 2024
Beam shines a light on phase 1/2 data with its base editing candidate for sickle cell disease ahead of a full presentation at ASH next month
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Elevance Health says star ratings snub cost insurer $375M
Fierce Healthcare
NOVEMBER 5, 2024
Yet another major insurer is taking the federal government to court over all-important star ratings results. | Elevance Health is hitting back at CMS star ratings over statistical variation and inability of replication in the latest lawsuit to face the feds.
Screen time and autism, TikTok and birth control, fighting disinformation
STAT
NOVEMBER 5, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Election Day is finally here. What to say? If you’re feeling at all grateful for STAT’s journalism today, consider supporting our newsroom. We’re currently offering 40% off our annual subscription.
Eliquis vs. Plavix: Key differences, uses, costs, and side effects
The Checkup by Singlecare
NOVEMBER 5, 2024
Two widely-used medications that reduce our ability to form blood clots, Eliquis and Plavix have very different uses and prices. Eliquis (apixaban) is only available as a brand-name tablet taken twice daily to treat or prevent blood clots in the heart, blood vessels, or lungs. Plavix ( clopidogrel ) has both brand and generic tablets available and put to use in the setting of heart attack, stroke, or peripheral arterial disease.
Disc maps out US filing for porphyria drug bitopertin
pharmaphorum
NOVEMBER 5, 2024
Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.Shares in the company gained almost 24% after it announced that the end of phase 2 meeting with the US regulator had firmed up plans for a phase 3 trial of bitopertin in EPP, as well as the potential for accelerated approval.
AstraZeneca stock tanks over fears of expanding China fraud probe
Fierce Pharma
NOVEMBER 5, 2024
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a local report fueled fears of a potentially escalating insurance fraud investigation in China. | AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially escalating insurance fraud investigation in China.
CRUK backs AI-powered, virtual radiotherapy trial projects
pharmaphorum
NOVEMBER 5, 2024
Cancer Research UK awards £5.
Investors reevaluate this year’s obesity darling
STAT
NOVEMBER 5, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. Hope everyone takes it easy in what will be a long day today. Now let’s get into the biotech news.
PP-007 Receives FDA Fast Track Designation for Treatment of Acute Ischemic Stroke
Pharmacy Times
NOVEMBER 5, 2024
The novel therapy demonstrated safety and efficacy in a clinical trial.
Seeking a single source of truth: Standardisation of the data model
pharmaphorum
NOVEMBER 5, 2024
Learn the importance of having a standardised data model as your single source of truth in this insightful video interview. Gain valuable insights on data management and standardisation processes.
How to Prep Your Pharmacy for Year-End Success in 2024
PioneerRx
NOVEMBER 5, 2024
Well, here we are: November, only two months until we welcome in the new year. As this year draws to a close, the last two months offer a powerful opportunity to.
Four key strategies for optimising your medical congress strategy
pharmaphorum
NOVEMBER 5, 2024
Learn about four key strategies for optimising your scientific medical congress strategy to maximise impact and engagement.
Novo Nordisk signs $285m deal with Ascendis to create once-monthly GLP-1RA
Pharmaceutical Technology
NOVEMBER 5, 2024
Ascendis Pharma will license its TransCon technology to Novo to develop therapies for metabolic and cardiovascular diseases.
STAT+: Supreme Court justices appear split on case over $9 billion hospital payment program
STAT
NOVEMBER 5, 2024
Tuesday’s oral arguments before the Supreme Court in a case involving billions in Medicare payments to hospitals revealed a split among the justices willing to show their cards. The case, Advocate Christ Medical Center v. Becerra, concerns Medicare payments to safety net hospitals, known as disproportionate share hospital, or DSH, payments, which are designed to compensate them for treating low-income patients.
Analysts point to Syfovre 'nadir' after Apellis discloses disappointing quarter
Fierce Pharma
NOVEMBER 5, 2024
Despite witnessing modest growth in demand over the past three months, Apellis Pharmaceuticals’ complement inhibitor for geographic atrophy (GA), Syfovre, may have hit a performance “nadir” in 2024 | Over the latest earnings stretch, Apellis' Syfovre saw sales down about 2% from the previous quarter despite an overall demand increase of about 7%.
STAT+: Pharmalittle: We’re reading about Medicaid coverage of obesity drugs, a death in a sickle cell trial, and more
STAT
NOVEMBER 5, 2024
Good morning, everyone, and how are you today? We are doing just fine, thank you, despite cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and crisp autumn breezes are wafting by. Moreover, this is an exciting day on this side of the pond, where millions of voters are casting their ballots in hopes of changing their world.
Let's personalize your content